Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) EPS (Basic): 2009-2025

Historic EPS (Basic) for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$0.03.

  • Lifecore Biomedical's EPS (Basic) rose 87.50% to -$0.03 in Q2 2025 from the same period last year, while for May 2025 it was -$1.28, marking a year-over-year decrease of 487.88%. This contributed to the annual value of -$1.27 for FY2025, which is 425.64% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's EPS (Basic) is -$0.03, which was up 93.62% from -$0.47 recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical's EPS (Basic) peaked at $0.51 during Q1 2024, and registered a low of -$1.88 during Q2 2022.
  • For the 3-year period, Lifecore Biomedical's EPS (Basic) averaged around -$0.35, with its median value being -$0.33 (2024).
  • As far as peak fluctuations go, Lifecore Biomedical's EPS (Basic) slumped by 6,166.67% in 2022, and later spiked by 209.30% in 2023.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's EPS (Basic) stood at -$1.31 in 2021, then soared by 67.18% to -$0.43 in 2022, then surged by 209.30% to $0.47 in 2023, then slumped by 153.19% to -$0.25 in 2024, then soared by 87.50% to -$0.03 in 2025.
  • Its EPS (Basic) stands at -$0.03 for Q2 2025, versus -$0.47 for Q1 2025 and -$0.25 for Q4 2024.